Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

As Halloween approaches, Exact Sciences is warding off a particularly terrifying occurrence: skipping colorectal cancer ...

With a Sept. 29 deadline looming for pharmaceutical companies to adhere to President Donald Trump’s Most Favored Nation drug ...

AI is now the first place people go to for answers,” according to Jesse Wolfersberger, global lead of I/O Health at Weber ...